Predictive value of prostate-specific antigen for prostate cancer: a nested case-control study in EuroSIDA.
Identifieur interne : 003291 ( PubMed/Checkpoint ); précédent : 003290; suivant : 003292Predictive value of prostate-specific antigen for prostate cancer: a nested case-control study in EuroSIDA.
Auteurs : Leah Shepherd [Royaume-Uni] ; Alvaro Humberto Borges [Danemark] ; Lene Ravn [Danemark] ; Richard Harvey [Royaume-Uni] ; Viard Jean-Paul [France] ; Mark Bower [Royaume-Uni] ; Andrew Grulich [Australie] ; Michael Silverberg [États-Unis] ; Stephane De Wit [Belgique] ; Ole Kirk [Danemark] ; Jens Lundgren [Danemark] ; Amanda Mocroft [Royaume-Uni]Source :
- Journal of the International AIDS Society [ 1758-2652 ] ; 2014.
Abstract
Although prostate cancer (PCa) incidence is lower in HIV+ men than in HIV- men, the usefulness of prostate-specific antigen (PSA) screening in this population is not well defined and may have higher false negative rates than in HIV- men. We aimed to describe the kinetics and predictive value of PSA in HIV+ men.
PubMed: 25394019
Affiliations:
- Australie, Belgique, Danemark, France, Royaume-Uni, États-Unis
- Angleterre, Grand Londres, Hovedstaden, Nouvelle-Galles du Sud, Région de Bruxelles-Capitale, Île-de-France
- Bruxelles, Copenhague, Londres, Paris, Sydney
- University College de Londres, Université Paris-Descartes
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:25394019Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Predictive value of prostate-specific antigen for prostate cancer: a nested case-control study in EuroSIDA.</title><author><name sortKey="Shepherd, Leah" sort="Shepherd, Leah" uniqKey="Shepherd L" first="Leah" last="Shepherd">Leah Shepherd</name><affiliation wicri:level="4"><nlm:affiliation>Department of Infection and Population Health, University College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Infection and Population Health, University College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author><author><name sortKey="Borges, Alvaro Humberto" sort="Borges, Alvaro Humberto" uniqKey="Borges A" first="Alvaro Humberto" last="Borges">Alvaro Humberto Borges</name><affiliation wicri:level="3"><nlm:affiliation>Centre for Health & Infectious Diseases Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Centre for Health & Infectious Diseases Research, Rigshospitalet, University of Copenhagen, Copenhagen</wicri:regionArea><placeName><settlement type="city">Copenhague</settlement><region type="région" nuts="2">Hovedstaden</region></placeName></affiliation></author><author><name sortKey="Ravn, Lene" sort="Ravn, Lene" uniqKey="Ravn L" first="Lene" last="Ravn">Lene Ravn</name><affiliation wicri:level="3"><nlm:affiliation>Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Department of Clinical Biochemistry, Rigshospitalet, Copenhagen</wicri:regionArea><placeName><settlement type="city">Copenhague</settlement><region type="région" nuts="2">Hovedstaden</region></placeName></affiliation></author><author><name sortKey="Harvey, Richard" sort="Harvey, Richard" uniqKey="Harvey R" first="Richard" last="Harvey">Richard Harvey</name><affiliation wicri:level="3"><nlm:affiliation>Charing Cross Oncology Laboratory and Trophoblast, Charing Cross Hospital Campus of Imperial College Healthcare National Health Service Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Charing Cross Oncology Laboratory and Trophoblast, Charing Cross Hospital Campus of Imperial College Healthcare National Health Service Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Jean Paul, Viard" sort="Jean Paul, Viard" uniqKey="Jean Paul V" first="Viard" last="Jean-Paul">Viard Jean-Paul</name><affiliation wicri:level="4"><nlm:affiliation>Centre de Diagnostic et de Thérapeutique, Université Paris Descartes, Hôtel-D, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Centre de Diagnostic et de Thérapeutique, Université Paris Descartes, Hôtel-D, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement><settlement type="city">Paris</settlement></placeName><orgName type="university">Université Paris-Descartes</orgName></affiliation></author><author><name sortKey="Bower, Mark" sort="Bower, Mark" uniqKey="Bower M" first="Mark" last="Bower">Mark Bower</name><affiliation wicri:level="3"><nlm:affiliation>National Centre for HIV Malignancy, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>National Centre for HIV Malignancy, Chelsea and Westminster Hospital NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Grulich, Andrew" sort="Grulich, Andrew" uniqKey="Grulich A" first="Andrew" last="Grulich">Andrew Grulich</name><affiliation wicri:level="3"><nlm:affiliation>Kirby Institute, The University of New South Wales, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Kirby Institute, The University of New South Wales, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Silverberg, Michael" sort="Silverberg, Michael" uniqKey="Silverberg M" first="Michael" last="Silverberg">Michael Silverberg</name><affiliation wicri:level="1"><nlm:affiliation>Division of Research, Kaiser Permanente Northern California, Oakland, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Research, Kaiser Permanente Northern California, Oakland</wicri:regionArea><wicri:noRegion>Oakland</wicri:noRegion></affiliation></author><author><name sortKey="De Wit, Stephane" sort="De Wit, Stephane" uniqKey="De Wit S" first="Stephane" last="De Wit">Stephane De Wit</name><affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, Saint-Pierre Hospital, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Infectious Diseases, Saint-Pierre Hospital, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Kirk, Ole" sort="Kirk, Ole" uniqKey="Kirk O" first="Ole" last="Kirk">Ole Kirk</name><affiliation wicri:level="3"><nlm:affiliation>Centre for Health & Infectious Diseases Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Centre for Health & Infectious Diseases Research, Rigshospitalet, University of Copenhagen, Copenhagen</wicri:regionArea><placeName><settlement type="city">Copenhague</settlement><region type="région" nuts="2">Hovedstaden</region></placeName></affiliation></author><author><name sortKey="Lundgren, Jens" sort="Lundgren, Jens" uniqKey="Lundgren J" first="Jens" last="Lundgren">Jens Lundgren</name><affiliation wicri:level="3"><nlm:affiliation>Centre for Health & Infectious Diseases Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Centre for Health & Infectious Diseases Research, Rigshospitalet, University of Copenhagen, Copenhagen</wicri:regionArea><placeName><settlement type="city">Copenhague</settlement><region type="région" nuts="2">Hovedstaden</region></placeName></affiliation></author><author><name sortKey="Mocroft, Amanda" sort="Mocroft, Amanda" uniqKey="Mocroft A" first="Amanda" last="Mocroft">Amanda Mocroft</name><affiliation wicri:level="4"><nlm:affiliation>Department of Infection and Population Health, University College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Infection and Population Health, University College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25394019</idno><idno type="pmid">25394019</idno><idno type="wicri:Area/PubMed/Corpus">003280</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003280</idno><idno type="wicri:Area/PubMed/Curation">003170</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003170</idno><idno type="wicri:Area/PubMed/Checkpoint">003170</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003170</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Predictive value of prostate-specific antigen for prostate cancer: a nested case-control study in EuroSIDA.</title><author><name sortKey="Shepherd, Leah" sort="Shepherd, Leah" uniqKey="Shepherd L" first="Leah" last="Shepherd">Leah Shepherd</name><affiliation wicri:level="4"><nlm:affiliation>Department of Infection and Population Health, University College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Infection and Population Health, University College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author><author><name sortKey="Borges, Alvaro Humberto" sort="Borges, Alvaro Humberto" uniqKey="Borges A" first="Alvaro Humberto" last="Borges">Alvaro Humberto Borges</name><affiliation wicri:level="3"><nlm:affiliation>Centre for Health & Infectious Diseases Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Centre for Health & Infectious Diseases Research, Rigshospitalet, University of Copenhagen, Copenhagen</wicri:regionArea><placeName><settlement type="city">Copenhague</settlement><region type="région" nuts="2">Hovedstaden</region></placeName></affiliation></author><author><name sortKey="Ravn, Lene" sort="Ravn, Lene" uniqKey="Ravn L" first="Lene" last="Ravn">Lene Ravn</name><affiliation wicri:level="3"><nlm:affiliation>Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Department of Clinical Biochemistry, Rigshospitalet, Copenhagen</wicri:regionArea><placeName><settlement type="city">Copenhague</settlement><region type="région" nuts="2">Hovedstaden</region></placeName></affiliation></author><author><name sortKey="Harvey, Richard" sort="Harvey, Richard" uniqKey="Harvey R" first="Richard" last="Harvey">Richard Harvey</name><affiliation wicri:level="3"><nlm:affiliation>Charing Cross Oncology Laboratory and Trophoblast, Charing Cross Hospital Campus of Imperial College Healthcare National Health Service Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Charing Cross Oncology Laboratory and Trophoblast, Charing Cross Hospital Campus of Imperial College Healthcare National Health Service Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Jean Paul, Viard" sort="Jean Paul, Viard" uniqKey="Jean Paul V" first="Viard" last="Jean-Paul">Viard Jean-Paul</name><affiliation wicri:level="4"><nlm:affiliation>Centre de Diagnostic et de Thérapeutique, Université Paris Descartes, Hôtel-D, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Centre de Diagnostic et de Thérapeutique, Université Paris Descartes, Hôtel-D, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement><settlement type="city">Paris</settlement></placeName><orgName type="university">Université Paris-Descartes</orgName></affiliation></author><author><name sortKey="Bower, Mark" sort="Bower, Mark" uniqKey="Bower M" first="Mark" last="Bower">Mark Bower</name><affiliation wicri:level="3"><nlm:affiliation>National Centre for HIV Malignancy, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>National Centre for HIV Malignancy, Chelsea and Westminster Hospital NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Grulich, Andrew" sort="Grulich, Andrew" uniqKey="Grulich A" first="Andrew" last="Grulich">Andrew Grulich</name><affiliation wicri:level="3"><nlm:affiliation>Kirby Institute, The University of New South Wales, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Kirby Institute, The University of New South Wales, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Silverberg, Michael" sort="Silverberg, Michael" uniqKey="Silverberg M" first="Michael" last="Silverberg">Michael Silverberg</name><affiliation wicri:level="1"><nlm:affiliation>Division of Research, Kaiser Permanente Northern California, Oakland, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Research, Kaiser Permanente Northern California, Oakland</wicri:regionArea><wicri:noRegion>Oakland</wicri:noRegion></affiliation></author><author><name sortKey="De Wit, Stephane" sort="De Wit, Stephane" uniqKey="De Wit S" first="Stephane" last="De Wit">Stephane De Wit</name><affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, Saint-Pierre Hospital, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Infectious Diseases, Saint-Pierre Hospital, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Kirk, Ole" sort="Kirk, Ole" uniqKey="Kirk O" first="Ole" last="Kirk">Ole Kirk</name><affiliation wicri:level="3"><nlm:affiliation>Centre for Health & Infectious Diseases Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Centre for Health & Infectious Diseases Research, Rigshospitalet, University of Copenhagen, Copenhagen</wicri:regionArea><placeName><settlement type="city">Copenhague</settlement><region type="région" nuts="2">Hovedstaden</region></placeName></affiliation></author><author><name sortKey="Lundgren, Jens" sort="Lundgren, Jens" uniqKey="Lundgren J" first="Jens" last="Lundgren">Jens Lundgren</name><affiliation wicri:level="3"><nlm:affiliation>Centre for Health & Infectious Diseases Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Centre for Health & Infectious Diseases Research, Rigshospitalet, University of Copenhagen, Copenhagen</wicri:regionArea><placeName><settlement type="city">Copenhague</settlement><region type="région" nuts="2">Hovedstaden</region></placeName></affiliation></author><author><name sortKey="Mocroft, Amanda" sort="Mocroft, Amanda" uniqKey="Mocroft A" first="Amanda" last="Mocroft">Amanda Mocroft</name><affiliation wicri:level="4"><nlm:affiliation>Department of Infection and Population Health, University College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Infection and Population Health, University College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author></analytic><series><title level="j">Journal of the International AIDS Society</title><idno type="eISSN">1758-2652</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Although prostate cancer (PCa) incidence is lower in HIV+ men than in HIV- men, the usefulness of prostate-specific antigen (PSA) screening in this population is not well defined and may have higher false negative rates than in HIV- men. We aimed to describe the kinetics and predictive value of PSA in HIV+ men.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">25394019</PMID><DateCreated><Year>2014</Year><Month>11</Month><Day>14</Day></DateCreated><DateCompleted><Year>2016</Year><Month>01</Month><Day>21</Day></DateCompleted><DateRevised><Year>2014</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1758-2652</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>4 Suppl 3</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>Journal of the International AIDS Society</Title><ISOAbbreviation>J Int AIDS Soc</ISOAbbreviation></Journal><ArticleTitle>Predictive value of prostate-specific antigen for prostate cancer: a nested case-control study in EuroSIDA.</ArticleTitle><Pagination><MedlinePgn>19510</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7448/IAS.17.4.19510</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Although prostate cancer (PCa) incidence is lower in HIV+ men than in HIV- men, the usefulness of prostate-specific antigen (PSA) screening in this population is not well defined and may have higher false negative rates than in HIV- men. We aimed to describe the kinetics and predictive value of PSA in HIV+ men.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Men with PCa (n=21) and up to two matched controls (n=40) with prospectively stored plasma samples before PCa (or matched date in controls) were selected. Cases and controls were matched on date of first and last sample, age, region of residence and CD4 count at first sample date. Total PSA (tPSA), free PSA (fPSA), testosterone and sex hormone binding globulin (SHBG) were measured. Conditional logistic regression models investigated associations between markers and PCa. Sensitivity and specificity of using tPSA >4 µg/L to predict PCa was calculated. Mixed models were used to describe kinetics.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixty-one men were included with a median six (IQR 2-9) years follow-up. Time between last sample and PCa was seven (4-11) months. Cases and controls were well matched at first sample, with a median age of 51 (IQR 48-57) and CD4 of 437 (243-610) cells/mm(3). Median tPSA [2.8 (IQR: 1.6-4.6) and 0.8 (0.5-1.2) µg/L] and fPSA [0.4 (0.2-0.8) and 0.3 (0.2-0.4) µg/L] levels were higher in cases than controls at first sample. Both tPSA and fPSA increased significantly over time in cases (Figure 1), to a median at last sample of 6.1 (4.7-9.5) and 0.9 (0.6-1.3) µg/L, respectively, but were stable in controls, with a median at last sample of 0.8 (0.5-1.4) and 0.2 (0.2-0.4) µg/L (Figure). Higher levels of tPSA and fPSA were associated with higher odds of PCa at first sample [OR for 2-fold higher 4.7 (CI: 1.7-12.9) and 5.4 (1.7-17.4)]. Elevated tPSA values in cases were detectable ≥5 years before PCa (p<0.01). Testosterone [overall median 19.4 (IQR 15.3-23.9) nmol/L at first sample) and SHBG [50.0 (34.0-66.0) nmol/L] levels were similar in cases and controls at first and last sample (all p>0.7). The most informative predictor of PCa was tPSA (AUC=0.9), followed by fPSA (0.8). Testosterone (AUC = 0.5) and SHBG (0.5) were poor predictors of PCa. Overall, tPSA level >4 µg/L had 99% specificity and 37% sensitivity. Performance was best in the year prior to PCa (specificity: 99%, sensitivity: 88%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PSA was highly predictive of PCa in HIV+ men. Our results indicate that PSA screening in HIV+ men may be useful, and further work is needed to identify potentially age-related cut-offs to maximize sensitivity and specificity to identify those for further evaluation at early stages of PCa.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shepherd</LastName><ForeName>Leah</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Infection and Population Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borges</LastName><ForeName>Alvaro Humberto</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Centre for Health & Infectious Diseases Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravn</LastName><ForeName>Lene</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harvey</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Charing Cross Oncology Laboratory and Trophoblast, Charing Cross Hospital Campus of Imperial College Healthcare National Health Service Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jean-Paul</LastName><ForeName>Viard</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Centre de Diagnostic et de Thérapeutique, Université Paris Descartes, Hôtel-D, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bower</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Centre for HIV Malignancy, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grulich</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Kirby Institute, The University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silverberg</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Research, Kaiser Permanente Northern California, Oakland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Wit</LastName><ForeName>Stephane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Saint-Pierre Hospital, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirk</LastName><ForeName>Ole</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Centre for Health & Infectious Diseases Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lundgren</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Health & Infectious Diseases Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mocroft</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Infection and Population Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>EuroSIDA in Eurocoord</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Int AIDS Soc</MedlineTA><NlmUniqueID>101478566</NlmUniqueID><ISSNLinking>1758-2652</ISSNLinking></MedlineJournalInfo><OtherID Source="NLM">PMC4224942</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25394019</ArticleId><ArticleId IdType="pii">19510</ArticleId><ArticleId IdType="pmc">PMC4224942</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Australie</li><li>Belgique</li><li>Danemark</li><li>France</li><li>Royaume-Uni</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Grand Londres</li><li>Hovedstaden</li><li>Nouvelle-Galles du Sud</li><li>Région de Bruxelles-Capitale</li><li>Île-de-France</li></region><settlement><li>Bruxelles</li><li>Copenhague</li><li>Londres</li><li>Paris</li><li>Sydney</li></settlement><orgName><li>University College de Londres</li><li>Université Paris-Descartes</li></orgName></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Shepherd, Leah" sort="Shepherd, Leah" uniqKey="Shepherd L" first="Leah" last="Shepherd">Leah Shepherd</name></region><name sortKey="Bower, Mark" sort="Bower, Mark" uniqKey="Bower M" first="Mark" last="Bower">Mark Bower</name><name sortKey="Harvey, Richard" sort="Harvey, Richard" uniqKey="Harvey R" first="Richard" last="Harvey">Richard Harvey</name><name sortKey="Mocroft, Amanda" sort="Mocroft, Amanda" uniqKey="Mocroft A" first="Amanda" last="Mocroft">Amanda Mocroft</name></country><country name="Danemark"><region name="Hovedstaden"><name sortKey="Borges, Alvaro Humberto" sort="Borges, Alvaro Humberto" uniqKey="Borges A" first="Alvaro Humberto" last="Borges">Alvaro Humberto Borges</name></region><name sortKey="Kirk, Ole" sort="Kirk, Ole" uniqKey="Kirk O" first="Ole" last="Kirk">Ole Kirk</name><name sortKey="Lundgren, Jens" sort="Lundgren, Jens" uniqKey="Lundgren J" first="Jens" last="Lundgren">Jens Lundgren</name><name sortKey="Ravn, Lene" sort="Ravn, Lene" uniqKey="Ravn L" first="Lene" last="Ravn">Lene Ravn</name></country><country name="France"><region name="Île-de-France"><name sortKey="Jean Paul, Viard" sort="Jean Paul, Viard" uniqKey="Jean Paul V" first="Viard" last="Jean-Paul">Viard Jean-Paul</name></region></country><country name="Australie"><region name="Nouvelle-Galles du Sud"><name sortKey="Grulich, Andrew" sort="Grulich, Andrew" uniqKey="Grulich A" first="Andrew" last="Grulich">Andrew Grulich</name></region></country><country name="États-Unis"><noRegion><name sortKey="Silverberg, Michael" sort="Silverberg, Michael" uniqKey="Silverberg M" first="Michael" last="Silverberg">Michael Silverberg</name></noRegion></country><country name="Belgique"><region name="Région de Bruxelles-Capitale"><name sortKey="De Wit, Stephane" sort="De Wit, Stephane" uniqKey="De Wit S" first="Stephane" last="De Wit">Stephane De Wit</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003291 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 003291 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:25394019
|texte= Predictive value of prostate-specific antigen for prostate cancer: a nested case-control study in EuroSIDA.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:25394019" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |